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Abstract 12 
The production of caseinophosphopeptides from a casein-derived by-product generated 13 
during the manufacture of a functional ingredient based on antihypertensive peptides 14 
was attempted. The casein by-product was submitted to tryptic hydrolysis during 30, 60, 15 
and 120 min and further precipitated with calcium chloride and ethanol at pH 4.0, 6.0 16 
and 8.0. The identification and semiquantification of the derived products by tandem 17 
mass spectrometry allowed to assess some qualitative and quantitative changes in the 18 
released caseinophophopeptides over time at the different precipitation pHs. The by-19 
product was also subjected to a simulated gastrointestinal digestion. Comparison of the 20 
resulting peptides showed the large sequence homology in the phosphopeptides released 21 
by tryptic hydrolysis and gastrointestinal digestion. Some regions, specifically αS1-CN 22 
43-59, αS1-CN 60-74, β-CN 1-25, and β-CN 30-50 showed resistance to both tryptic 23 
hydrolysis and simulated digestion. These results suggest that this casein-derived by-24 
product can be used as source of CPPs. 25 
 26 
 27 
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1. Introduction 33 
Caseinophosphopeptides (CPPs) are phosphorylated bioactive peptides that can be 34 
released from casein (CN) by in vivo or in vitro enzymatic digestion (Bouhallab & 35 
Bouglé, 2004). Some of them are characterized by the presence of three phosphoseryl 36 
groups followed by two residues of glutamic acid (SpSpSpEE). This motif is localized 37 
specifically in the sequences of αs1-CN f(66-70), αs2-CN f(8-12), αs2-CN f(56-60), and 38 
β-CN f(17-21). Due to the phosphorylated serines, these regions are relatively resistant 39 
to be further hydrolysed and it has been proposed that they could prevent the 40 
precipitation of metal ions at alkaline pH in the distal small intestine (Fitzgerald, 1998; 41 
Zidane et al., 2012). This property implies that CPPs could be used as supplements for 42 
fortifying foods, with a view to improving mineral bioavailability. Different 43 
applications of CPPs have been reported such as prevention of osteoporosis, 44 
oligoelement supplementation and prevention of dental caries, the last one being the 45 
most used therapeutic application (Cross, Huq, O'Brien-Simpson, Perich, Attard, & 46 
Reynolds, 2007). In addition, it has been proposed that they may also display 47 
immunomodulatory, cytomodulatory and antioxidant activities (Meisel & Fitzgerald, 48 
2003; Phelan, Aherne, Fitzgerald & O´Brien, 2009). Besides, CPPs can exert influence 49 
upon gastric secretion regulation (Guilloteau, Romé, Delaby, Mendy, Roger, & 50 
Chayvialle, 2009), and antimicrobial effects have been also reported (Arunachalam & 51 
Raja, 2010). 52 
CPPs have been released from αs1-, αs2-, β-, and κ-CN subjected to hydrolysis with 53 
different enzymes such as trypsin pancreatin, alcalase, plasmin, or combinations of 54 
them, such as trypsin and chymotrypsin (Pinto, Caira, Cuollo, Lilla, Chianese & Addeo, 55 
2012). The hydrolysis conditions were different taking into account the pH, time, 56 
enzyme:protein ratio and temperature, obtaining thus different sequences. In some 57 
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studies, the digests or hydrolysates are subjected to an enrichment step to isolate the 58 
generated CPPs. Selective precipitation with CaCl2 and ethanol is a usual method using 59 
pHs in the range 3.5 to 8.5. It has been reported that at pH 3.5 only peptides containing 60 
the phosphorylated cluster sequence SpSpSpEE selectively precipitate from a tryptic 61 
digest of casein. However, at pH 4.6, the precipitate contained di- and tri-62 
phosphorylated peptides. At pH 8.0, an increase of the recoveries of the di- and 63 
monophosphorylated peptides was observed (Aoki et al., 1998; Reynolds, Riley, & 64 
Adamson, 1994; Zhao, Wang, & Zu, 2007). Whether the pH used during precipitation 65 
could determine the characteristics of the products recovered remains to be evidenced 66 
using a powerful identification technique such as tandem mass spectrometry (MS/MS). 67 
Some animal studies have demonstrated the formation of CPPs after the ingestion of 68 
CN or its fractions (Kasai, Honda, & Kiriyama, 1992; Meisel & Frister, 1989; Naito & 69 
Suzuki, 1974). In humans, CPPs have been identified after the ingestion of milk, yogurt 70 
and CN (Boutrou et al., 2013; Chabance et al., 1998). CPPs sharing some amino acid 71 
sequences with them have been found using gastro-analogous digestion (pepsin) of β-72 
CN (Schmelzer, Schöps, Reynell, Ulbrich-Hofmann, Neubert, & Raith, 2007) or using 73 
simulated gastrointestinal digestion of CN with pepsin and trypsin (Ono, Takagi, & 74 
Kunishi, 1998) or pepsin and pancreatin (Miquel, Gómez, Alegría, Barberá, Farré, & 75 
Recio, 2006).  76 
The production of CPPs for commercial purposes is usually performed from the 77 
whole casein fraction, CN or sodium caseinate. The aim of this work was to evaluate if 78 
a by-product generated during the manufacture of an antihypertensive hydrolysate from 79 
caseins (Contreras et al., 2011), could be used as substrate to obtain CPPs. From this 80 
by-product, CPPs were released by tryptic hydrolysis, concentrated by selective 81 
precipitation with CaCl2 and ethanol at three pH values (4.0, 6.0 and 8.0), and identified 82 
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by HPLC-MS/MS. Moreover, the generation of CPPs was also evaluated after a 83 
hydrolysis process that simulates gastrointestinal digestion with the aim to investigate if 84 
CPPs could be also released from this CN-derived by-product during passage through 85 
the intestinal tract. 86 
 87 
2. Materials and methods 88 
 89 
2.1 Samples 90 
The CN-derived by-product obtained during the production of a hydrolysate with 91 
antihypertensive properties was provided by Innaves, S.A. (Porriño, Spain). The 92 
hydrolysate is prepared by pepsin digestion of commercial CN (Promilk 85®) from 93 
Arras Cedex (France) as described in Contreras et al. (2011). 94 
 95 
2.2 Protein, moisture, and mineral content.  96 
Moisture of commercial CN and CN-derived by-product was determined by drying 97 
for 3 h in an oven at 100-105ºC (International Dairy Federation, 1964). Protein amount 98 
was determined by the Kjeldahl method (International Dairy Federation, 1993). Mineral 99 
composition (Ca, P, K, Mg, and Na) was determined by inductively-coupled plasma 100 
emission spectrometry (ICP) using a Perkin Elmer Optima 4300 DV plasma emission 101 
spectrometer (Waltham, MA, USA). The analysis were performed in triplicate. Analysis 102 
of variance (ANOVA) was carried out using the test of confidence intervals at 95%. 103 
 104 
2.3 SDS-PAGE 105 
Samples were diluted to 1 mg/mL in sample buffer containing 2% (w/v) SDS and 106 
5% (v/v) β-mercaptoethanol and heated at 95°C for 4 min. Samples were analysed in 107 
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duplicate on Precast Criterion XT 12% Bis-Tris gels and electrophoretic separations 108 
were carried out at 150 V using XT-MES as running buffer (Bio-Rad, Richmond, CA, 109 
USA), in the Criterion cell (Bio-Rad). Gels were stained with Bio-Safe Coomassie G-110 
250 (Bio-Rad). 111 
 112 
2.4 Preparation of CPPs  113 
2.4.1 Hydrolysis with trypsin 114 
Ten grams of CN-derived by-product were dissolved in Milli-Q water, and adjusted 115 
to pH 8.0 with 5 M NaOH. Food-grade trypsin (Biocatalysts, Nantgarw, UK) was added 116 
at final ratio of 2.0% w/w of substrate. Hydrolysis was performed at 50°C for 2 h with 117 
the pH maintained in the range 7.7-8.5 by the addition of 1 M NaOH. After hydrolysis, 118 
the pH was adjusted to pH 4.6 by the addition of 1 M HCl and insoluble material 119 
formed was removed by centrifugation (12000 × g for 10 min at 10ºC). 120 
 121 
2.4.2 Simulated gastrointestinal digestion 122 
CN-derived by-product was subjected to a gastric and duodenal digestion according 123 
to Jiménez-Saiz, Martos, Carrillo, López-Fandiño R, and Molina (2011). The enzymes 124 
and reagents used in the simulated gastrointestinal digestion were purchased from 125 
Sigma-Aldrich (St. Louis, MO, USA). Briefly, the samples were dissolved in simulated 126 
gastric fluid, 0.35 M NaCl, mixed with vesicles containing phosphatidylcholine (9.58 127 
mg/mL) and the pH was adjusted to 2.0 with 0.5 M HCl. The samples were pre-heated 128 
for 15 min at 37ºC, digested with porcine pepsin (EC 3.4.23.1, 3640 U/mg protein) at 129 
182 U/mg protein, and incubated for 60 min at 37 ºC. Then gastric digests were adjusted 130 
to pH 7.0 by adding 0.5 M NaHCO3. 131 
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Then, the supernatants of the gastric digests were re-adjusted to pH 6.5 by addition 132 
of 0.1 M NaHCO3, 0.125 M bile salts equimolar mixture of sodium taurocholate and 133 
sodium glycodeoxycholate and 1 M CaCl2 (7.6 mM final concentration). The samples 134 
were pre-heated at 37ºC for 15 min. After, pancreatic porcine lipase (EC 232-619-9, 135 
type VI-S, 47900 U/mg protein) at 24.75 U/mg protein, pancreatic porcine colipase (EC 136 
259-490-1) at 1:895 w/w protein, pancreatic bovine trypsin (EC 232-650-8, type I 137 
10100 U/mg protein) at 34.5 U/mg protein, pancreatic bovine α-chymotrypsin (EC 232-138 
671-2; type I–S; 55 U/mg protein) at 0.44 U/mg protein were added to the duodenal 139 
mixture, and incubated at 37 °C for 60 min. Then, the digestion was stopped by heating 140 
at 80°C for 5 min. 141 
 142 
2.5 Isolation of CPPs by selective precipitation 143 
CPPs in tryptic hydrolysate and gastrointestinal digest were precipitated according 144 
to Adamson and Reynolds (1995). The pH was adjusted to 4.0, 6.0 or 8.0 and CPPs 145 
were precipitated by the addition of 10% (w/v) CaCl2 (20 mol/mol protein) and an equal 146 
volume of 99.8% (v/v) ethanol was added slowly with mixing. The suspension was 147 
centrifuged (12000 × g for 10 min at 10ºC), and the precipitate was washed with 50% 148 
(v/v) ethanol, lyophilized and stored at -20ºC until further analysis. 149 
 150 
2.6 Analysis of CPPs by on-line RP-HPLC–ESI-MS/MS 151 
The analysis of CPPs was carried out on-line by RP-HPLC MS/MS using an 152 
Esquire-LC quadrupole ion-trap mass spectrometer (Bruker Daltonics, GmbH, Bremen, 153 
Germany) (García-Nebot, Alegría, Barberá, Contreras, & Recio, 2010). The column 154 
used was (XBridge TM BEH 300 C18 5µm, 4.6 × 250 mm, Waters), the injection volume 155 
was 50 µL, and the flow was set at 0.8 mL/min. The flow was split post UV detector by 156 
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connecting a T-piece to give a flow of approx. 20 µL/min to be directed to the mass 157 
spectrometer nebulizer.  158 
Freeze-dried samples (2.5 mg) were dissolved in 1 mL of 0.1% (v/v) trifluoroacetic acid 159 
(TFA) (Sigma-Aldrich). Solvent A was a mixture of Milli-Q/TFA (1000:0.37, v/v), and 160 
solvent B contained acetonitrile (HPLC grade)/TFA (1000:0.27, v/v). The gradient was 161 
60% of solvent B in 90 min, after which the percentage of solvent B increased to 90% 162 
in 5 min and remained constant at 90% for 5 min. 163 
The m/z spectral data were processed and transformed to spectra representing mass 164 
values using Data Analysis version 4.0. Bio Tools version 3.2 (Bruker Daltoniks) was 165 
used to process the MS(n) spectra and perform peptide sequencing. The semi-166 
quantification of the CPPs was performed by obtaining the extracted ion chromatograms 167 
(EIC) and integration of the peak area thereof, after signal normalization to the total 168 
peak area. 169 
 170 
3. Results and discussion 171 
3.1 Characterization of the commercial casein, by-product and hydrolysed products 172 
Table 1 shows the protein, moisture and mineral content (Ca, P, K, Mg, Na, and Fe) 173 
determined in the commercial CN, substrate of the hydrolysis process, and in the 174 
corresponding CN-derived by-product. The contents in the commercial CN were similar 175 
to those given by the manufacturer. The protein content found in the CN by-product 176 
was lower than that of the commercial CN due to the industrial process (Contreras et al., 177 
2011). All mineral content values showed significant (p < 0.05) differences between 178 
both samples. The K content was higher in the by-product, since food-grade KOH was 179 
added during the hydrolysis process, whereas Ca, P, Mg, and Na contents were higher 180 
in the commercial CN. The P content of the by-product represented more than 70% of 181 
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the content in the commercial CN on a protein basis. This led us to consider the by-182 
product a suitable source to obtain CPPs.  183 
Figure 1 shows the SDS-PAGE electrophoretic separation of the commercial CN, 184 
the CN-derived by-product, the product of its hydrolysis with trypsin during 120 min 185 
and after its simulated gastrointestinal digestion. The bands corresponding to the CN 186 
were intense in the commercial CN, although bands corresponding to residual serum 187 
proteins as β-Lg and α-La could be observed too (Lane 2 in Fig.1). In the CN-derived 188 
by-product bands corresponding to αs1-, αs2-, and β-CN were observed, as well as other 189 
intense bands of lower molecular weight that corresponded to CN fragments, i.e., CN 190 
partly hydrolysed generated by the action of pepsin during the production of the 191 
antihypertensive ingredient  (Lane 3 in the Fig.1). 192 
When the CN-derived by-product was subjected to tryptic hydrolysis small 193 
amounts of intact αs2- and β-CN and partly hydrolysed CN were observed (Lane 4 in the 194 
Fig. 1). However, other intact CN fractions were not observed, indicating that CN 195 
fractions are mostly digested. Similar results were observed in the sample submitted to 196 
gastrointestinal digestion, although even less intact CNs could be detected. These 197 
results were confirmed when the CN-derived by-product was analyzed by (RP-HPLC) 198 
(data not shown). 199 
 200 
3.2 Preparation of CPPs by hydrolysis with trypsin  201 
The tryptic hydrolysis (30, 60 and 120 min) of the CN-derived by-product was 202 
followed by selective precipitation at pH values of 4.0, 6.0 and 8.0 in order to cover the 203 
acidic-basic region, giving rise to nine different tryptic hydrolysates. A total of 44 CPPs 204 
were identified, of which, 13 corresponded to αs1-CN, 11 to αs2-CN, 18 to β-CN, and 205 
two to κ-CN (Table 2). It must be pointed out that 13 of the identified CPPs presented 206 
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the cluster sequence (SpSpSpEE). They corresponded to αs1-CN f(61-79), αs2-CN f(1-207 
20), αs2-CN f(46-70) and β-CN f(1-25) or fragments thereof. All of the peptides were 208 
found in every hydrolysis product, with the exception of αs1-CN (61-79)5P, which was 209 
only found in the precipitates at pH 8.0. Only two protein fragments corresponded to κ-210 
CN. This may be due to its low content in bovine milk and to scarcity of phosphoseryl 211 
residues in this protein. 212 
The identified peptides contained as C-terminal residue the amino acids Gln, 213 
Lys, Arg, Asn, Glu, Ile, Ser, Asp, Leu, Tyr, Thr, and Phe. Some of these cleavage sites 214 
cannot be explained on the basis of the trypsin specificity, thus being due the 215 
chymotrypsin and carboxypeptidases present in the commercial food-grade trypsin and 216 
to previous cleavages by the action of pepsin during the production of the 217 
antihypertensive hydrolysate. This is in accordance to the non-trypsin-like activity 218 
observed by Adamson and Reynolds (1995) in the Na caseinate hydrolysis with an 219 
industrial-grade trypsin. Five peptides showed a lower number of phosphorylated 220 
residues than maximal number allowed which could be due to incomplete Ser 221 
phosphorylation or to the high temperature employed during the by-product drying 222 
process. Dephosphorylation of the Ser 46 in αs1-CN f(38-48)1P, Ser 64 and Ser 66 in 223 
αs1-CN f(59-71)2P and Ser 15 in β-CN f(1-25)3P or f(8-22)2P had previously been 224 
shown in tryptic hydrolysates (Ellegard, Gammelgard-Larsen, Sörensen, & Fedosov, 225 
1999; Zhu & Fitzgerald, 2010). Other potential phosphorylated sites that were not 226 
phosphorylated in our samples corresponded to Ser 48 in αs1-CN f(38-48)1P, Ser 56 in 227 
SpSpSpEE and Ser 17 in f(8-22)2P, although  dephosphorylation at these positions by 228 
heat treatment had not previously reported. 229 
In order to follow the release of CPPs during the tryptic hydrolysis, a relative 230 
quantification of the identified sequences was conducted at the hydrolysis times studied. 231 
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The pH used during the selective precipitation can be a source of qualitative or 232 
quantitative changes. Thus, when comparing pH 4.6 and 8.0, it has been reported that 233 
relevant amounts of mono and diphosphorylated peptides were obtained predominantly 234 
at pH 8.0 (Reynolds et al., 1994; Adamson & Reynolds, 1995). Figure 2A shows the 235 
relative abundance of four related (10 common amino acid residues) diphosphorylated 236 
peptides arisen from αs1-CN at the three different precipitation pHs used. In agreement 237 
with the mentioned studies, the pH 8.0 precipitates showed higher relative amounts than 238 
the pH 4.0 and 6.0 precipitates. Conversely, CPPs with more than two phosphorylated 239 
residues showed a different behaviour. Figure 2B shows the relative recovery of peptide 240 
αs2-CN f(56-68)3P, which presented a higher yield at the pH 6.0 precipitate at all the 241 
studied times. When considering the effect of the hydrolysis time, it was observed that 242 
this peptide was formed from 30 min and its relative amount decreased at 120 min of 243 
tryptic hydrolysis. This reflects its susceptibility to degradation by trypsin in long-term 244 
conditions.  245 
To study the influence of the hydrolysis time on the amount of a CPP showing the 246 
cluster sequence SpSpSpEE, we determined the relative amounts of the well-247 
characterized β-CN f(1-25)4P and four derived peptides with the same C-terminal end 248 
in the pH 8.0 precipitates over time (Figure 3). A clear decrease was shown by β-CN 249 
f(1-25)4P together with the increase in β-CN f(7-25)4P and f(12-25)4P, showing some 250 
susceptibility of the parent peptide to the trypsin activity. In contrast, no relevant 251 
changes were observed for β-CN f(2-25)4P and β-CN f(17-25)3P. The importance of 252 
the structural conformation conferred by both, the acidic motif SpSpSpEE and the 253 
preceding N-terminal portion, in relation to the biological activity is known (Ferraretto,  254 
Gravaghi, Fiorilli, & Tettamanti, 2003). From the fragments whose amount is increased 255 
in the pH 8.0 precipitates, only β-CN f(7-25)4P shows the N-terminal located amino 256 
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acids necessary to preserve the activity. This is the peptide showing a more steep 257 
increase over time. It is then expected that, despite the decrease of the β-CN f(1-25)4P, 258 
the increase in β-CN f(7-25)4P would help to keep the biological activity of the CPP 259 
pool after 120 min of hydrolysis. The decrease in β-CN f(1-25)4P is in accordance with 260 
the results of Su, Qi, He, Yuan, and Zhang (2007) who identified the same 261 
phosphopeptide from 10 min to 1 hour of pancreatin hydrolysis of CN, but not at 2 h. 262 
However, these authors could not identify the derived fragments above mentioned. 263 
 264 
3.3 CPPs released after simulated gastrointestinal digestion 265 
A total of 37 CPPs, of which 13 corresponded to αs1-CN, 8 to αs2-CN, 16 to β-CN 266 
and two to κ-CN were identified after simulated gastrointestinal digestion of the CN-267 
derived by-product. Figure 4 shows the comparison of the tryptic and gastrointestinal 268 
digestion products in the CN amino acid sequences. By using simulated gastrointestinal 269 
digestion phosphorylated peptides belonging to the same domains that those generated 270 
by tryptic hydrolysis were found. Furthermore, the pattern of resistant regions to trypsin 271 
hydrolysis is very close to that of simulated digestion (90% of the amino acid residues). 272 
Only small differences between sequences were found and make that the common CPPs 273 
identified in the trypsin hydrolysates and in the simulated gastrointestinal digests 274 
represented 73% of the total number of sequenced peptides. Well characterized CPPs 275 
such as β-CN f(1-25)4P and, αs1-CN f(43-58)2P and αs2-CN f(56-68)3P and fragments 276 
thereof were found using trypsin hydrolysis and simulated digestion.  277 
In this regard, similar peptide profile had been shown between the CN and/or β-CN 278 
tryptic hydrolysates (in vitro conditions) and the intestinal content of rats fed a CN- 279 
and/or β-CN based diet (in vivo conditions), although Lys and Arg residues were lost in 280 
the case of CN and β-CN based diet, respectively, compared to in vitro conditions 281 
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(Naito & Suzuki, 1974; Sato et al., 1991). In addition, the peptide αs1-CN f(66-74)3P 282 
was found in the duodenal content of minipigs fed a CN-based diet (Meisel & Frister, 283 
1989), which presents the same cleavage than αs1-CN f(61-74)4P and αs1-CN f(62-284 
74)4P, and overlaps with αs1-CN f(59-71)2P found in our digest (Figure 4). These 285 
cleavages are also in agreement with those of peptides αs1-CN f(62-69)4P and αs1-CN 286 
f(64-73)4P identified by Kasai et al. (1992) in feces of rats fed a CN-based diet. In this 287 
context, β-CN f(33-44)4P found in our study was also identified in the human stomach 288 
after milk intake after 20 min (Chabance et al., 1998).  289 
In jejunal effluents of humans, after CN consumption, Boutrou et al. (2013) found 290 
β-CN f(33-48)1P and αs1-CN f(110-119)1P, two sequences found in our study, as well 291 
as the fragment αs2-CN f(138-146)1P that overlaps with the peptides αs2-CN f(138-292 
147)1P and αs2-CN f(138-149)1P (Figure 4). These results indicate that the simulated 293 
gastrointestinal digestion can release some CPPs similar to those formed in vivo, in 294 
agreement with the observations reported previously by García-Nebot et al. (2010). 295 
These authors reported the resistance of CPPs pool when they were added to fruit 296 
beverages and subjected to simulated gastrointestinal digestion. Most of the added CPPs 297 
to the fruit beverage were recovered after digestion, although they lacked one or two 298 
amino acid residues at the C- or N-terminal end. 299 
Picariello et al. (2010) studied the formation of peptides after simulated digestion 300 
with pepsin and a mixture of trypsin, chymotrypsin, carboxypeptidase and elastase 301 
followed by incubation with extracts of human intestinal brush border membranes. The 302 
CPPs enrichment was performed by selective isolation on TiO2 micro-column. In this 303 
study, the αs1-CN region 104-119 was covered by six CPPs, in contrast with the unique 304 
peptide αs1-CN f(110-119) found in our samples. However, they reported no peptide in 305 
the αs1-CN region 43-59 where numerous CPPs appeared in our samples. In the β-CN 306 
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sequence, numerous peptides were identified around the β-CN region 30-52 in 307 
agreement with our results. However, the N-terminal end was only represented in two 308 
β-CN f(1-25) peptides while none of the five derived fragments present in our digested 309 
samples were found. This had been also the case in the study  of Su et al. (2007), where 310 
pancreatin was used and no CPP isolation procedure was applied. In a study on the 311 
intestinal brush-border enzymes action on β-CN f(1-25) it has been reported that, in 312 
addition to phosphorylation, binding cations might prevent CPP from hydrolysis 313 
(Boutrou et al., 2010). Therefore, some of the differences found between studies using 314 
in vitro hydrolysis could be attributed to the different mineral content of the substrate 315 
and the hydrolysis or gastrointestinal digestion conditions applied. 316 
In animal studies, Bouhallab et al. (1999) evaluated the sensitivity of β-CN f(1-317 
25)4P to digestive enzymes using a duodenal loop system in rats, and the fragments β-318 
CN f(2-25)4P and β-CN f(7-25)4P were found. Both cleavage sites (Arg1-Glu2 and 319 
Asn6-Val7) have been also found in our study. Likewise, αs1-CN f(59-71)2P, αs1-CN 320 
f(61-74)4P and αs1-CN f(62-74)4P identified in our digested sample overlap with the 321 
main peptide, αs1-CN f(59-79)5P, found in the ileum of rats after administration by 322 
stomach gavage of a CPPs pool (Brommage, Juillerat, & Jost, 1991). In the ileum 323 
extract of rats after ingestion of a CPPs preparation, αs1-CN f(61-74)4P and β-CN f(7-324 
24)4P were identified. The first sequence is present in our digest while the second 325 
overlaps with β-CN f(7-25)4P (Hirayama, Toyota, Hidaka, & Naito, 1992).  326 
The CN regions where a larger amount of peptides both in tryptic hydrolysates and 327 
simulated digests has been identified are αs1-CN 43-59, β-CN 1-25 and β-CN 30-43. 328 
These regions are characterized by a high hydrophobicity at pH 3.0 (gastric conditions) 329 
and/or the presence of post-translational modifications, parameters that have already 330 
been identified as playing a key role in the resistance of CN to in vitro digestion 331 
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(Dupont et al., 2010). These facts suggest the resistance of these peptides in the case of 332 
the CN-derived by-product being ingested. 333 
 334 
4. Conclusions 335 
The results in this study show that the partially hydrolysed CN fraction obtained as a 336 
by-product during the production of an antihypertensive hydrolysate can be further 337 
exploited as source of CPPs. The identification and semiquantitative determination of 338 
CPPs has shown that the selection of the tryptic hydrolysis time and precipitation pH 339 
can modulate the recovery of specific phosphorylated sequences. This can be important 340 
in view of selecting the conditions where the length of the N-terminal portion preceding 341 
the phosphoserine cluster SpSpSpEE in the CPP is enough to keep the biological 342 
activity. Identification of CPPs in the samples of CN-derived by-product after being 343 
subjected to simulated gastrointestinal digestion (aiming to mimic what would occur in 344 
an in vivo digestion) has shown that this process generates CPP sequences very similar 345 
to those produced by tryptic hydrolysis. These results suggest that this CN-derived by-346 
product can be used as a source for CPPs after its passage through the gastrointestinal 347 
tract opening the door for its use as functional ingredient to improve mineral 348 
bioavailability. Because the phosphorylated regions of CN are resistant to hydrolysis, it 349 
is likely that many of the by-products or insoluble fractions generated during milk 350 
protein hydrolysis, for instance, in the manufacture of active hydrolysates or hydrolysed 351 
infant formulas, could be further exploited as CPPs sources. 352 
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Figure captions 476 
Figure 1. SDS-PAGE analysis of commercial casein, casein-derived by-product and the 477 
product of its hydrolysis with trypsin or simulated gastrointestinal digestion under 478 
reducing conditions. Lane 1: Molecular marker; Lane 2: Commercial casein; Lane 3: 479 
Casein derived by-product; Lane 4: Casein-derived by product hydrolyzed with trypsin 480 
for 120 min; Lane 5: Casein derived by-product subjected to simulated gastrointestinal 481 
digestion. 482 
 483 
Figure 2. Relative amount of A) Peptides f(43-52), f(43-55,) f(43-56) and f(43-59) from 484 
αs1-CN at 120 min hydrolysis time and at the precipitation pHs 4.0, 6.0 and 8.0 and B) 485 
αs2-CN f(56-68)3P hydrolysis times 30, 60, and 120 min at the precipitation pHs 4.0, 486 
6.0 and 8.0. 487 
 488 
Figure 3. Relative amount of β-CN f(1-25)4P, f(7-25)4P, f(12-25)4P, f(17-25)3P and 489 
f(2-25)4P after 30, 60 and 120 min of tryptic hydrolysis with selective precipitation at 490 
pH 8.0. 491 
 492 
Figure 4. Caseinophosphopeptides sequences identified from casein derived by-product 493 
subjected to hydrolysis with trypsin (solid line) and after simulated gastrointestinal 494 
digestion (dotted line). Sp Indicates Phosphoserine; SPSPSPEE Indicates cluster 495 
sequence; * Indicates Serine residue without phosphate. 496 
 497 
 498 
 499 
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Table 1. Moisture, protein and mineral content of casein and casein-derived by-product 500 
(expressed as %, w/w)  501 
Component  Casein Casein-derived by-product 
Moisture 5.022   ± 0.010 4.999 ± 0.020 
Protein  79.960   ± 0.152 71.052 ± 0.339* 
Ca 2.506   ± 0.437 0.418 ± 0.027* 
P 1.144   ± 0.030 0.788 ± 0.040* 
K 0.362   ± 0.014 0.478 ± 0.034* 
Mg 0.092   ± 0.003 0.016 ± 0.001* 
Na 0.066   ± 0.004 0.022 ± 0.001* 
*indicates significant differences (p<0.05). Data are expressed as mean ± standard deviation (n = 3) 
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Table 2. Caseinophopshopeptides identified in the CN-derived by product subjected to hydrolysis with 
trypsin. Observed mass, calculated mass and ion (m/z) selected for MS/MS analysis, where the charge of 
the ion is given between brackets. 
 
Protein fragment 
 
Amino acid sequences 
 
Observed 
mass 
Calculated 
mass 
Ion m/z 
(charge) 
αs1-CN f(28-42)1P FPEVFGKEKVNELSpK 1828.9 1829.8 1829.9(+1)
αs1-CN f(38-48)1P NELSpKDIGSES 1258.5 1257.5 1259.5(+1)
αs1-CN f(43-52)2P DIGSpESpTEDQ 1239.4 1239.3 1240.4(+1)
αs1-CN f(43-55)2P DIGSpESpTEDQAME 1570.6 1570.4 1571.6(+1)
αs1-CN f(43-56)2P DIGSpESpTEDQAMED 1685.6 1685.5 1686.6(+1)
αs1-CN f(43-58)2P DIGSpESpTEDQAMEDIK   1926.7 1926.6 1927.7(+1)
αs1-CN f(43-59)2P DIGSpESpTEDQAMEDIKQ 2054.8 2054.7 2055.8(+1)
αs1-CN f(44-59)2P IGSpESpTEDQAMEDIKQ 1940.8 1939.7 1941.8(+1)
αs1-CN f(59-71)2P QMEAESISSpSpEEI 1598.6 1598.5 1599.6(+1)
αs1-CN f(61-74)4P EAESpISpSpSpEEIVPN 1808.9 1809.5 1809.9(+1)
αs1-CN f(61-79)5P* EAESpISpSpSpEEIVPNSpVEQK 2462.0 2460.8 1232.0(+2)
αs1-CN f(62-74)4P AESpISpSpSpEEIVPN 1680.8 1680.5 1681.8(+1)
αs1-CN f(110-119)1P EIVPNSpAEER 1222.6 1222.5 1223.6(+1)
αs2-CN f(1-20)4P KNTMEHVSpSpSpEESIISpQETY 2618.0 2617.8 1310.0(+2)
αs2-CN f(37-58)3P STFCKEVVRNANEEEYSIGSpSpSp 2678.2 2677.0 1340.1(+2)
αs2-CN f(46-70)4P NANEEEYSIGSpSpSpEESpAEVATEEVK 3008.2 3007.0 1505.1(+2)
αs2-CN f(53-70)4P SIGSpSpSpEESpAEVATEEVK 2157.7 2157.7 2158.7(+1)
αs2-CN f(56-68)3P SSpSpEESpAEVATEE 1592.5 1593.4 1593.5(+1)
αs2-CN f(117-132)2P VPITPTLNREQLSpTSpE 1942.7 1943.8 1943.7(+1)
αs2-CN f(126-136)2P EQLSpTSpEENSK 1410.5 1410.4 1411.5(+1)
αs2-CN f(126-137)2P EQLSpTSpEENSKK 1538.7 1538.5 1539.7(+1)
αs2-CN f(138-147)1P TVDMESpTEVF 1236.5 1236.4 1237.5(+1)
αs2-CN f(138-149)1P TVDMESpTEVFTK 1465.6 1465.6 1466.6(+1)
αs2-CN f(138-150)1P TVDMESpTEVFTKK 1593.7 1593.7 1594.7(+1)
β-CN f(1-25)4P RELEELNVPGEIVESpLSpSpSpEESITR 3122.4 3121.2 1562.2(+2)
β-CN f(1-25)3P RELEELNVPGEIVESLSpSpSpEESITR 3042.4 3041.2 1522.2(+2)
β-CN f(2-25)4P RELEELNVPGEIVESpLSpSpSpEESITR 2966.4 2965.1 1484.2(+2)
β-CN f(2-18)3P ELEELNVPGEIVESpLSpSp 2082.8 2082.8 2083.8(+1)
β-CN f(4-25)4P EELNVPGEIVESpLSpSpSpEESITR 2724.2 2723.0 1363.1(+2)
β-CN f(7-25)4P NVPGEIVESpLSpSpSpEESITR 2352.0 2351.8 2353.0(+1)
β-CN f(8-22)2P VPGEIVESLSSpSpEES 1707.5 1707.6 1708.5(+1)
β-CN f(12-25)4P IVESpLSpSpSpEESITR 1855.7 1855.6 1856.7(+1)
β-CN f(17-25)3P SpSpSpEESITR 1234.4 1234.3 1235.4(+1)
β-CN f(30-44)1P IEKFQSpEEQQQTEDE 1946.9 1946.7 1947.9(+1)
β-CN f(30-48)1P IEKFQSpEEQQQTEDELQDK 2432.2 2431.0 1217.1(+2)
β-CN f(31-46)1P EKFQSpEEQQQTEDELQ 2074.7 2074.8 2075.7(+1)
β-CN f(33-44)1P FQSpEEQQQTEDE 1576.7 1576.5 1577.7(+1)
β-CN f(33-45)1P FQSpEEQQQTEDEL 1689.7 1689.6 1690.7(+1)
β-CN f(33-46)1P FQSpEEQQQTEDELQ 1817.8 1817.6 1818.8(+1)
β-CN f(33-47)1P FQSpEEQQQTEDELQD 1932.8 1932.7 1933.8(+1)
β-CN f(33-48)1P FQSpEEQQQTEDELQDK 2060.9 2060.8 2061.9(+1)
β-CN f(33-52)1P FQSpEEQQQTEDELQDKIHPF 2556.2 2555.0 1279.1(+2)
k-CN f(147-161)1P EDSpPEVIESPPEINT 1734.8 1734.7 1735.8(+1)
k-CN f(146-161)1P LEDSpPEVIESPPEINT 1847.9 1847.8 1848.9(+1)
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Sp: phosphoserine residue; SpSpSpEE: Cluster Sequence. *indicates that this phosphopeptide only has been identified in the pH 8 precipitate. 
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